2023 Q2 Form 10-Q Financial Statement

#000086474923000077 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q2
Revenue $993.6M $915.4M $993.7M
YoY Change -0.01% 12.07%
Cost Of Revenue $389.1M $354.6M $444.1M
YoY Change -12.38% 12.95%
Gross Profit $604.5M $560.8M $549.6M
YoY Change 9.99% 11.41%
Gross Profit Margin 60.84% 61.26% 55.31%
Selling, General & Admin $296.6M $246.1M $233.4M
YoY Change 27.08% 12.32%
% of Gross Profit 49.07% 43.88% 42.47%
Research & Development $174.8M $159.3M $140.3M
YoY Change 24.59% 8.42%
% of Gross Profit 28.92% 28.41% 25.53%
Depreciation & Amortization $72.20M $9.800M $10.00M
YoY Change 622.0% -2.91%
% of Gross Profit 11.94% 1.75% 1.82%
Operating Expenses $503.3M $423.8M $392.7M
YoY Change 28.16% 11.44%
Operating Profit $101.2M $137.0M $156.9M
YoY Change -35.5% 11.36%
Interest Expense -$38.70M -$8.300M -$6.300M
YoY Change 514.29% 23.53%
% of Operating Profit -38.24% -6.06% -4.02%
Other Income/Expense, Net $1.500M $23.60M -$18.40M
YoY Change -108.15% 425.71%
Pretax Income $57.50M $160.6M $138.5M
YoY Change -58.48% 0.8%
Income Tax $12.90M $31.80M $28.20M
% Of Pretax Income 22.43% 19.8% 20.36%
Net Earnings $44.60M $128.8M $110.3M
YoY Change -59.56% -3.67%
Net Earnings / Revenue 4.49% 14.07% 11.1%
Basic Earnings Per Share $0.18 $0.52 $0.44
Diluted Earnings Per Share $0.18 $0.52 $0.44
COMMON SHARES
Basic Shares Outstanding 247.7M shares 247.0M shares 250.8M shares
Diluted Shares Outstanding 249.0M shares 248.7M shares 252.8M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $237.3M $1.038B $357.2M
YoY Change -33.57% 35.0%
Cash & Equivalents $237.3M $1.038B $357.2M
Short-Term Investments
Other Short-Term Assets $189.4M $212.6M $151.6M
YoY Change 24.93% 26.23%
Inventory $371.4M $409.4M $401.0M
Prepaid Expenses
Receivables $664.1M $578.8M $655.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.462B $2.239B $1.566B
YoY Change -6.6% 24.25%
LONG-TERM ASSETS
Property, Plant & Equipment $347.1M $215.1M $235.0M
YoY Change 47.7% -6.6%
Goodwill $5.560B $4.177B $3.971B
YoY Change 40.01% 3.2%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $783.7M $352.4M $295.4M
YoY Change 165.3% 16.25%
Total Long-Term Assets $8.094B $5.774B $5.612B
YoY Change 44.23% 1.66%
TOTAL ASSETS
Total Short-Term Assets $1.462B $2.239B $1.566B
Total Long-Term Assets $8.094B $5.774B $5.612B
Total Assets $9.556B $8.013B $7.177B
YoY Change 33.14% 5.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $180.2M $166.5M $213.3M
YoY Change -15.52% 35.09%
Accrued Expenses $172.0M $130.8M $144.6M
YoY Change 18.95% -0.41%
Deferred Revenue $640.5M $659.3M $622.7M
YoY Change 2.86% 10.92%
Short-Term Debt $4.300M $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $4.300M $300.0M
YoY Change
Total Short-Term Liabilities $1.301B $1.481B $1.247B
YoY Change 4.34% 8.28%
LONG-TERM LIABILITIES
Long-Term Debt $3.185B $1.787B $1.294B
YoY Change 146.17% 0.14%
Other Long-Term Liabilities $386.3M $138.0M $147.7M
YoY Change 161.54% -1.53%
Total Long-Term Liabilities $3.571B $1.925B $147.7M
YoY Change 2317.74% -1.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.301B $1.481B $1.247B
Total Long-Term Liabilities $3.571B $1.925B $147.7M
Total Liabilities $5.225B $3.768B $3.190B
YoY Change 63.82% 2.66%
SHAREHOLDERS EQUITY
Retained Earnings $2.381B $2.356B $2.170B
YoY Change 9.71% 10.63%
Common Stock $2.144B $2.108B $1.982B
YoY Change 8.22% 7.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.331B $4.245B $3.988B
YoY Change
Total Liabilities & Shareholders Equity $9.556B $8.013B $7.177B
YoY Change 33.14% 5.85%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q2
OPERATING ACTIVITIES
Net Income $44.60M $128.8M $110.3M
YoY Change -59.56% -3.67%
Depreciation, Depletion And Amortization $72.20M $9.800M $10.00M
YoY Change 622.0% -2.91%
Cash From Operating Activities $142.4M $208.7M $153.0M
YoY Change -6.93% -32.95%
INVESTING ACTIVITIES
Capital Expenditures $12.60M $6.400M $14.50M
YoY Change -13.1% 36.79%
Acquisitions $33.30M $0.00
YoY Change -100.0%
Other Investing Activities -$2.010B -$12.00M -$1.100M
YoY Change 182618.18% -21.43%
Cash From Investing Activities -$2.022B -$27.70M -$13.40M
YoY Change 14993.28% 45.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $104.7M
YoY Change 227.19%
Debt Paid & Issued, Net $523.4M $118.8M
YoY Change -64.61%
Cash From Financing Activities 1.079B $583.4M -$109.7M
YoY Change -1083.23% -41.31%
NET CHANGE
Cash From Operating Activities 142.4M $208.7M $153.0M
Cash From Investing Activities -2.022B -$27.70M -$13.40M
Cash From Financing Activities 1.079B $583.4M -$109.7M
Net Change In Cash -801.5M $767.1M $31.50M
YoY Change -2644.44% 17.1%
FREE CASH FLOW
Cash From Operating Activities $142.4M $208.7M $153.0M
Capital Expenditures $12.60M $6.400M $14.50M
Free Cash Flow $129.8M $202.3M $138.5M
YoY Change -6.28% -36.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000864749
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.72
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-14845
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
TRIMBLE INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-2802192
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
10368 Westmoor Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Westminster
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80021
CY2023Q1 dei City Area Code
CityAreaCode
720
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
887-6100
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
TRMB
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
247746800 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1038100000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
271000000.0 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
578800000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
643300000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
409400000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
402500000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
212600000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
201400000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
2238900000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1518200000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
215100000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
219000000.0 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
113200000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
121200000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
4176600000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4137900000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
484300000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
498100000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
432400000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
438400000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
352400000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
336200000 usd
CY2023Q1 us-gaap Assets
Assets
8012900000 usd
CY2022Q4 us-gaap Assets
Assets
7269000000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
300000000.0 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
300000000.0 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
166500000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
175500000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
130800000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
159400000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
659300000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
639100000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
224300000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
188100000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1480900000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1462100000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1786900000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1220000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
101500000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
98500000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
119900000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
157800000 usd
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
40900000 usd
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
40900000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99600000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
105100000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
138000000.0 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
134400000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
3767700000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3218800000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000.0 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000.0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000.0 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000.0 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
247400000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
247400000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
246900000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
246900000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
200000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
200000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2107500000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2054900000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2355900000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2230000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-218400000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-234900000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4245200000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4050200000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8012900000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7269000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
915400000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
993700000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
23000000.0 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
22500000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
354600000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
444100000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
560800000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
549600000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
159300000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
140300000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
135400000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
131900000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
110700000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
101500000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
6700000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
6900000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11700000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12100000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
423800000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
392700000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
137000000.0 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
156900000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-19700000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-16000000.0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11400000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9700000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31900000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12100000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23600000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18400000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
160600000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
138500000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31800000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28200000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
128800000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
110300000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
247200000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
250800000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
248700000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
252800000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
128800000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
110300000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19700000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2200000 usd
CY2023Q1 trmb Other Comprehensive Income Loss Cash Flow Hedge And Defined Benefit Plan Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeAndDefinedBenefitPlanGainLossAfterReclassificationAndTax
3200000 usd
CY2022Q2 trmb Other Comprehensive Income Loss Cash Flow Hedge And Defined Benefit Plan Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeAndDefinedBenefitPlanGainLossAfterReclassificationAndTax
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
145300000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
108100000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
128800000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
110300000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
9800000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
10000000.0 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
34700000 usd
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
34600000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-33800000 usd
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-16800000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
33500000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
28300000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
26900000 usd
CY2022Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
100000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
900000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16800000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-62100000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34600000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11100000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42700000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6200000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
14600000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9100000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7800000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-26500000 usd
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-75600000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
19500000 usd
CY2022Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
73300000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
34800000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
56300000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
208700000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
153000000.0 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
33300000 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6400000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14500000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-12000000.0 usd
CY2022Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1100000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27700000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13400000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14000000.0 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-2400000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
104700000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1097100000 usd
CY2022Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
118800000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
523400000 usd
CY2022Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
118800000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4300000 usd
CY2022Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2600000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
583400000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-109700000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2700000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1600000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
767100000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
31500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271000000.0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
325700000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1038100000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
357200000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepared our interim Condensed Consolidated Financial Statements that accompany these notes in conformity with U.S. GAAP, consistent in all material respects with those applied in our Form 10-K filed with the U.S. Securities and Exchange Commission on February 17, 2023 (the “2022 Form 10-K”).</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim financial information is unaudited, and reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This report should be read in conjunction with our 2022 Form 10-K that includes additional information about our significant accounting policies and the methods and assumptions used in our estimates. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates and assumptions are used for revenue recognition, including determining the nature and timing of satisfaction of performance obligations and determining standalone selling price (“SSP”) of performance obligations, provision for credit losses, sales returns reserve, inventory valuation, warranty costs, investments, acquired intangibles, goodwill and intangible asset impairment analysis, other long-lived asset impairment analysis, stock-based compensation, and income taxes. We base our estimates on historical experience and various other assumptions we believe to be reasonable. Actual results that we experience may differ materially from our estimates.</span></div>
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
993700000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
22500000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
444100000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1708200000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1223900000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
484300000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1706400000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1208300000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
498100000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
101700000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
111800000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
76200000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
70000000.0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
56300000 usd
CY2023Q1 trmb Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
68300000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
484300000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4137900000 usd
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
22500000 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-16200000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
4176600000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
149000000.0 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
154900000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
16100000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13100000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
244300000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
234500000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
409400000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
402500000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
578800000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
409400000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
4176600000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
643300000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
402500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4137900000 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
34700000 usd
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
34600000 usd
CY2023Q1 trmb Acquisition And Divestiture Related Costs
AcquisitionAndDivestitureRelatedCosts
7000000.0 usd
CY2022Q2 trmb Acquisition And Divestiture Related Costs
AcquisitionAndDivestitureRelatedCosts
3900000 usd
CY2023Q1 trmb Share Based Payment Arrangement And Deferred Compensation Arrangement With Individual Compensation Expense
ShareBasedPaymentArrangementAndDeferredCompensationArrangementWithIndividualCompensationExpense
35400000 usd
CY2022Q2 trmb Share Based Payment Arrangement And Deferred Compensation Arrangement With Individual Compensation Expense
ShareBasedPaymentArrangementAndDeferredCompensationArrangementWithIndividualCompensationExpense
25000000.0 usd
CY2023Q1 trmb Restructuring Charges And Other Costs
RestructuringChargesAndOtherCosts
12000000.0 usd
CY2022Q2 trmb Restructuring Charges And Other Costs
RestructuringChargesAndOtherCosts
12700000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
137000000.0 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
156900000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23600000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18400000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
160600000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
138500000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
13100000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5000000.0 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2086900000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1520000000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
300000000.0 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
300000000.0 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1786900000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1220000000 usd
CY2023Q1 trmb Short Term Debt Gross
ShortTermDebtGross
300000000.0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
400000000.0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q1 trmb Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1400000000 usd
CY2023Q1 trmb Debt Long Term And Short Term Combined Amount Gross
DebtLongTermAndShortTermCombinedAmountGross
2100000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1200000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
737600000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
631800000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
293500000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
234600000 usd
CY2023Q1 trmb Contract With Customer Liability Billings And Revenue Recognized Net
ContractWithCustomerLiabilityBillingsAndRevenueRecognizedNet
316700000 usd
CY2022Q2 trmb Contract With Customer Liability Billings And Revenue Recognized Net
ContractWithCustomerLiabilityBillingsAndRevenueRecognizedNet
306700000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
760800000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
703900000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1600000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
128800000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
110300000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
247200000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
250800000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1500000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000.0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
248700000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
252800000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.198
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.204
CY2023Q1 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
782500000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000864749-23-000077-index-headers.html Edgar Link pending
0000864749-23-000077-index.html Edgar Link pending
0000864749-23-000077.txt Edgar Link pending
0000864749-23-000077-xbrl.zip Edgar Link pending
a1022002stockplan-formofst.htm Edgar Link pending
a1032002stockplan-formofpe.htm Edgar Link pending
a1042002stockplan-formofpe.htm Edgar Link pending
a105ageandserviceequityves.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trmb-1stq2023xex311.htm Edgar Link pending
trmb-1stq2023xex312.htm Edgar Link pending
trmb-1stq2023xex321.htm Edgar Link pending
trmb-1stq2023xex322.htm Edgar Link pending
trmb-20230331.htm Edgar Link pending
trmb-20230331.xsd Edgar Link pending
trmb-20230331_g1.jpg Edgar Link pending
trmb-20230331_lab.xml Edgar Link unprocessable
trmb-20230331_cal.xml Edgar Link unprocessable
trmb-20230331_def.xml Edgar Link unprocessable
trmb-20230331_pre.xml Edgar Link unprocessable
trmb-20230331_htm.xml Edgar Link completed